mitomycin has been researched along with Pulmonary Veno Occlusive Disease in 12 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "All patients displayed squamous anal cancer and were treated with MMC alone or MMC plus 5-fluoruracil." | 5.42 | Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models. ( Antigny, F; Chaumais, MC; Cottin, V; Dorfmüller, P; Girerd, B; Godinas, L; Günther, S; Hautefort, A; Humbert, M; Jaïs, X; Montani, D; Perros, F; Ranchoux, B; Raymond, N; Savale, L; Simonneau, G; Sitbon, O, 2015) |
| "Mitomycin was incriminated in both cases." | 5.31 | Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. ( Capron, F; Gagnadoux, F; Lebeau, B, 2002) |
| "All patients displayed squamous anal cancer and were treated with MMC alone or MMC plus 5-fluoruracil." | 1.42 | Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models. ( Antigny, F; Chaumais, MC; Cottin, V; Dorfmüller, P; Girerd, B; Godinas, L; Günther, S; Hautefort, A; Humbert, M; Jaïs, X; Montani, D; Perros, F; Ranchoux, B; Raymond, N; Savale, L; Simonneau, G; Sitbon, O, 2015) |
| "Mitomycin was incriminated in both cases." | 1.31 | Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. ( Capron, F; Gagnadoux, F; Lebeau, B, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Certain, MC | 1 |
| Chaumais, MC | 6 |
| Jaïs, X | 4 |
| Savale, L | 5 |
| Seferian, A | 2 |
| Parent, F | 1 |
| Georges, M | 1 |
| Favrolt, N | 1 |
| Bourdin, A | 1 |
| Boissin, C | 1 |
| Cottin, V | 3 |
| Traclet, J | 1 |
| Renard, S | 1 |
| Noel, V | 1 |
| Picard, F | 1 |
| Girerd, B | 3 |
| Ghigna, MR | 1 |
| Perros, F | 4 |
| Sitbon, O | 4 |
| Bonniaud, P | 1 |
| Humbert, M | 6 |
| Montani, D | 6 |
| Zhang, C | 1 |
| Lu, W | 1 |
| Luo, X | 1 |
| Liu, S | 1 |
| Li, Y | 1 |
| Zheng, Q | 1 |
| Liu, W | 1 |
| Wu, X | 1 |
| Chen, Y | 1 |
| Jiang, Q | 1 |
| Zhang, Z | 1 |
| Gu, G | 1 |
| Chen, J | 1 |
| Chen, H | 1 |
| Liao, J | 1 |
| Liu, C | 1 |
| Hong, C | 1 |
| Tang, H | 1 |
| Sun, D | 1 |
| Yang, K | 1 |
| Wang, J | 1 |
| De Jesus Perez, VA | 1 |
| Zamanian, RT | 1 |
| Dorfmuller, P | 3 |
| O'Connell, C | 1 |
| Guignabert, C | 1 |
| Günther, S | 2 |
| Ranchoux, B | 2 |
| Godinas, L | 2 |
| Antigny, F | 2 |
| Hautefort, A | 2 |
| Raymond, N | 2 |
| Simonneau, G | 2 |
| Fabrice, A | 1 |
| Benoît, R | 1 |
| Valérie, N | 1 |
| Lau, E | 1 |
| Sébastien, B | 1 |
| Frédéric, P | 1 |
| Belge, C | 1 |
| Quarck, R | 1 |
| Delcroix, M | 1 |
| Koyama, M | 1 |
| Yano, T | 1 |
| Kikuchi, K | 1 |
| Mizuno, M | 1 |
| Nagano, N | 1 |
| Hashimoto, A | 1 |
| Miura, T | 1 |
| Gagnadoux, F | 1 |
| Capron, F | 1 |
| Lebeau, B | 1 |
12 other studies available for mitomycin and Pulmonary Veno Occlusive Disease
| Article | Year |
|---|---|
Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
Topics: Antibiotics, Antineoplastic; Cardiac Catheterization; Female; France; Functional Status; Humans; Hyp | 2021 |
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats.
Topics: Animals; Endothelial Cells; Endothelium; Humans; Hypertension, Pulmonary; Mitomycin; Pulmonary Veno- | 2021 |
No Good Deed Goes Unpunished: Mitomycin-Induced Pulmonary Venoocclusive Disease and Cancer.
Topics: Humans; Mitomycin; Neoplasms; Pulmonary Veno-Occlusive Disease | 2021 |
Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Female; Fluorouracil; Humans; Hypert | 2017 |
Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension.
Topics: Adverse Drug Reaction Reporting Systems; Antibiotics, Antineoplastic; Attitude of Health Personnel; | 2018 |
Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
Topics: Adult; Animals; Antibiotics, Antineoplastic; Anus Neoplasms; Disease Models, Animal; Female; Humans; | 2015 |
A simple method to assess in vivo proliferation in lung vasculature with EdU: the case of MMC-induced PVOD in rat.
Topics: Animals; Capillaries; Cell Proliferation; Cytological Techniques; Deoxyuridine; Endothelial Cells; F | 2015 |
Letter by Belge et al Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models".
Topics: Animals; Antibiotics, Antineoplastic; Disease Models, Animal; Female; Humans; Male; Mitomycin; Pulmo | 2016 |
Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model".
Topics: Animals; Antibiotics, Antineoplastic; Disease Models, Animal; Female; Humans; Male; Mitomycin; Pulmo | 2016 |
Favorable response to an endothelin receptor antagonist in mitomycin-induced pulmonary veno-occlusive disease with pulmonary capillary hemangiomatosis.
Topics: Aged; Endothelin Receptor Antagonists; Fatal Outcome; Female; Hemangioma, Capillary; Humans; Mitomyc | 2016 |
[Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication].
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Anus Neoplasms; Humans; Hypertension, Pulmonary; M | 2017 |
Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma.
Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Echocardiogr | 2002 |